CRIS logo

CRIS
Curis Inc

13,564
Mkt Cap
$15.51M
Volume
4.00
52W High
$4.50
52W Low
$1.02
PE Ratio
-0.34
CRIS Fundamentals
Price
$1.25
Prev Close
$1.20
Open
$1.22
50D MA
$1.44
Beta
0.86
Avg. Volume
102,865.21
EPS (Annual)
-$6.88
P/B
-1.08
Rev/Employee
$320,823.53
Loading...
Loading...
News
all
press releases
Curis to Present at Upcoming 30th Annual SNO Meeting
Curis to Present at Upcoming 30th Annual SNO Meeting Curis to Present at Upcoming 30th Annual SNO Meeting PR Newswire LEXINGTON, Mass., Nov. 14, 2025 LEXINGTON, Mass., Nov. 14, 2025 /PRNewswire...
PR Newswire·20d ago
News Placeholder
More News
News Placeholder
Curis (CRIS) Reports Q3 Loss, Beats Revenue Estimates
Curis (CRIS) delivered earnings and revenue surprises of +20.97% and +8.58%, respectively, for the quarter ended September 2025. Do the numbers hold clues to what lies ahead for the stock?
Zacks·28d ago
News Placeholder
Curis Provides Third Quarter 2025 Business Update
Curis Provides Third Quarter 2025 Business Update Curis Provides Third Quarter 2025 Business Update PR Newswire LEXINGTON, Mass., Nov. 6, 2025 Management to host conference call and webcast today at...
PR Newswire·28d ago
News Placeholder
Curis to Report Third Quarter 2025 Financial and Operating Results and Host Conference Call and Webcast on November 6, 2025
Curis to Report Third Quarter 2025 Financial and Operating Results and Host Conference Call and Webcast on November 6, 2025 Curis to Report Third Quarter 2025 Financial and Operating Results and Host...
PR Newswire·1mo ago
News Placeholder
Curis (CRIS) Reports Q2 Loss, Beats Revenue Estimates
Curis (CRIS) delivered earnings and revenue surprises of +65.83% and +14.54%, respectively, for the quarter ended June 2025. Do the numbers hold clues to what lies ahead for the stock?
Zacks·4mo ago
News Placeholder
Curis Announces Additional Data from TakeAim Leukemia Study
Curis Announces Additional Data from TakeAim Leukemia Study Curis Announces Additional Data from TakeAim Leukemia Study PR Newswire LEXINGTON, Mass., Dec. 10, 2024 LEXINGTON, Mass., Dec. 10, 2024...
PR Newswire·1y ago
News Placeholder
Curis Provides Third Quarter 2024 Business Update
Curis Provides Third Quarter 2024 Business Update Curis Provides Third Quarter 2024 Business Update PR Newswire LEXINGTON, Mass., Nov. 14, 2024 Management to host conference call today at 8:30 a.m...
PR Newswire·1y ago
News Placeholder
Curis to Report Third Quarter 2024 Financial and Operating Results and Host Conference Call and Webcast on November 14, 2024
Curis to Report Third Quarter 2024 Financial and Operating Results and Host Conference Call and Webcast on November 14, 2024 Curis to Report Third Quarter 2024 Financial and Operating Results and...
PR Newswire·1y ago
News Placeholder
Curis Announces $12.1 Million Registered Direct and Concurrent Private Placement
Curis Announces $12.1 Million Registered Direct and Concurrent Private Placement Curis Announces $12.1 Million Registered Direct and Concurrent Private Placement PR Newswire LEXINGTON, Mass., Oct...
PR Newswire·1y ago
News Placeholder
Curis Announces the 3rd Annual Symposium on IRAK4 in Cancer
Curis Announces the 3rd Annual Symposium on IRAK4 in Cancer Curis Announces the 3rd Annual Symposium on IRAK4 in Cancer PR Newswire LEXINGTON, Mass., Sept. 23, 2024 Symposium hosted by Eric S. Winer...
PR Newswire·1y ago

Latest CRIS News

View

Advertisement|Remove ads.

Advertisement|Remove ads.